We here provide evidence that metronomic, low dose topotecan treatment leads to DNA-damage, p21WAF/CIP1 up-regulation, senescence and tumor regression in vitro and in vivo selectively in MNA NB cells. Here, CDKN1A is linked to neuroblastoma.